BRCA1 and esophageal cancer: In the whole cohort, 144 esophageal cancer patients had a mOS of 13.0 months (95% CI: 11.5–14.5 months), without statistical significance between the high and low expression of BRCA1 (13.0 vs 12.8, P = 0.817) (Figure 1).